Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.23.3
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net loss available to stockholders $ (481,573) $ (256,712) $ (2,751,711) $ (1,023,521)
Weighted average shares outstanding - basic 24,850,261 24,850,261 24,850,261 24,850,261
Effect of dilutive securities:        
Weighted average shares outstanding - Diluted 24,850,261 24,850,261 24,850,261 24,850,261
Net income (loss) per share - basic (in USD per share) $ (0.02) $ (0.01) $ (0.11) $ (0.04)
Net income (loss) per share - diluted (in usd per share) $ (0.02) $ (0.01) $ (0.11) $ (0.04)
Stock Options        
Effect of dilutive securities:        
Stock options 0 0 0 0
Anti-dilutive shares underlying stock options outstanding 1,829,051 971,001 1,829,051 836,001